Search Results

There are 6247 results for: content related to: Population pharmacokinetics of abacavir in infants, toddlers and children

  1. Abacavir Pharmacogenetics – From Initial Reports to Standard of Care

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 7, July 2013, Pages: 765–775, Michael A. Martin and Deanna L. Kroetz

    Version of Record online : 3 MAY 2013, DOI: 10.1002/phar.1278

  2. You have free access to this content
    N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo

    British Journal of Pharmacology

    Volume 167, Issue 6, November 2012, Pages: 1353–1361, C Charneira, NM Grilo, SA Pereira, ALA Godinho, EC Monteiro, MM Marques and AMM Antunes

    Version of Record online : 19 OCT 2012, DOI: 10.1111/j.1476-5381.2012.02079.x

  3. You have free access to this content
    Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts

    HIV Medicine

    Volume 11, Issue 5, May 2010, Pages: 334–344, P Munderi, AS Walker, C Kityo, AG Babiker, F Ssali, A Reid, JH Darbyshire, H Grosskurth, P Mugyenyi, DM Gibb, CF Gilks and on behalf of the DART/NORA trial teams

    Version of Record online : 2 FEB 2010, DOI: 10.1111/j.1468-1293.2009.00786.x

  4. You have free access to this content
    Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study

    HIV Medicine

    Volume 11, Issue 2, February 2010, Pages: 130–136, N Obel, DK Farkas, G Kronborg, CS Larsen, G Pedersen, A Riis, C Pedersen, J Gerstoft and HT Sørensen

    Version of Record online : 13 AUG 2009, DOI: 10.1111/j.1468-1293.2009.00751.x

  5. Abacavir Pharmacokinetics During Chronic Therapy in HIV-1-Infected Adolescents and Young Adults

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 4, April 2009, Pages: 394–401, JW Sleasman, BL Robbins, SJ Cross, JC Lindsey, JM Kraimer, BE Heckman, HL Sprenger, NB Tustin, CH Rose, PA Poston, EF Neal, GE Pakes, M Nikanjam and EV Capparelli

    Version of Record online : 31 DEC 2008, DOI: 10.1038/clpt.2008.236

  6. You have free access to this content
    Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS

    Intervention Review

    The Cochrane Library

    Muki S Shey, Eugene J Kongnyuy, Samuel M Alobwede and Charles S Wiysonge

    Published Online : 28 MAR 2013, DOI: 10.1002/14651858.CD005481.pub3

  7. You have full text access to this OnlineOpen article
    Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA)

    Tropical Medicine & International Health

    Volume 13, Issue 1, January 2008, Pages: 6–16, Dart Trial Team

    Version of Record online : 17 FEB 2008, DOI: 10.1111/j.1365-3156.2007.01973.x

  8. You have free access to this content
    Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

    Intervention Review

    The Cochrane Library

    Mario Cruciani, Carlo Mengoli, Giovanni Serpelloni, Saverio G Parisi, Marina Malena and Oliviero Bosco

    Published Online : 5 JUN 2013, DOI: 10.1002/14651858.CD008270.pub2

  9. You have free access to this content
    Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART

    Tropical Medicine & International Health

    Volume 16, Issue 2, February 2011, Pages: 200–204, Paula Munderi, Wendy B. Snowden, Ann Sarah Walker, Cissy Kityo, Michael Mosteller, Geoffrey Kabuye, Navdeep K. Thoofer, Francis Ssali, Charles F. Gilks, Arlene R. Hughes and on behalf of the DART Trial Team

    Version of Record online : 23 NOV 2010, DOI: 10.1111/j.1365-3156.2010.02688.x

  10. You have free access to this content
    Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 4, April 2012, Pages: 734–738, M A Martin, T E Klein, B J Dong, M Pirmohamed, D W Haas and D L Kroetz

    Version of Record online : 29 FEB 2012, DOI: 10.1038/clpt.2011.355

    This article corrects:
  11. You have free access to this content
    Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response

    HIV Medicine

    Volume 9, Issue 1, January 2008, Pages: 27–40, A Cozzi-Lepri and on behalf of the Standardization and Clinical Relevance of HIV Drug Resistance Testing Project for the Forum for Collaborative HIV Research

    Version of Record online : 10 JAN 2008, DOI: 10.1111/j.1468-1293.2008.00523.x

  12. You have free access to this content
    Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA

    Allergy

    Volume 67, Issue 11, November 2012, Pages: 1338–1346, J. Yun, J. Adam, D. Yerly and W. J. Pichler

    Version of Record online : 3 SEP 2012, DOI: 10.1111/all.12008

  13. You have full text access to this OnlineOpen article
    Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 4, April 2014, Pages: 361–371, Tomoko Kurita, Tomomi Kitaichi, Takako Nagao, Toshiyuki Miura and Yoshifumi Kitazono

    Version of Record online : 3 MAR 2014, DOI: 10.1002/pds.3589

  14. Abacavir Pharmacokinetics in Human Immunodeficiency Virus-Infected Children Ranging in Age From 1 Month to 16 Years: A Population Analysis

    The Journal of Clinical Pharmacology

    Volume 45, Issue 3, March 2005, Pages: 257–264, Dr Vincent Jullien, Dr Saïk Urien, Dr Hélène Chappuy, Dr Jérǒme Dimet, Dr Elisabeth Rey, Dr Gérard Pons, Dr Stéphane Blanche and Dr Jean-Marc Tréluyer MD

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004272215

  15. The structural basis of HLA-associated drug hypersensitivity syndromes

    Immunological Reviews

    Volume 250, Issue 1, November 2012, Pages: 158–166, Yuri A. Pompeu, Jon D. Stewart, Simon Mallal, Elizabeth Phillips, Bjoern Peters and David A. Ostrov

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1600-065X.2012.01163.x

  16. You have free access to this content
    Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers

    British Journal of Clinical Pharmacology

    Volume 73, Issue 4, April 2012, Pages: 641–650, Wei Zhao, Massimo Cella, Oscar Della Pasqua, David Burger, Evelyne Jacqz-Aigrain and on behalf of Pediatric European Network for Treatment of AIDS (PENTA) 15 study group

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1365-2125.2011.04121.x

  17. You have free access to this content
    Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients

    British Journal of Clinical Pharmacology

    Volume 59, Issue 2, February 2005, Pages: 183–188, V. Jullien, J.-M. Tréluyer, H. Chappuy, J. Dimet, E. Rey, N. Dupin, D. Salmon, G. Pons and S. Urien

    Version of Record online : 22 DEC 2004, DOI: 10.1111/j.1365-2125.2004.02259.x

  18. Pharmacogenomics of off-target adverse drug reactions

    British Journal of Clinical Pharmacology

    Volume 83, Issue 9, September 2017, Pages: 1896–1911, Sarah L. Garon, Rebecca K. Pavlos, Katie D. White, Nancy J. Brown, Cosby A. Stone Jr and Elizabeth J. Phillips

    Version of Record online : 27 APR 2017, DOI: 10.1111/bcp.13294

  19. Successful implementation of a national HLA-B*5701 genetic testing service in Canada

    Tissue Antigens

    Volume 75, Issue 1, January 2010, Pages: 12–18, R. G. Lalonde, R. Thomas, A. Rachlis, M. J. Gill, M. Roger, J. B. Angel, G. Smith, N. Higgins and B. Trottier

    Version of Record online : 15 OCT 2009, DOI: 10.1111/j.1399-0039.2009.01383.x

  20. You have free access to this content
    British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015

    HIV Medicine

    Volume 17, Issue S4, August 2016, Pages: s2–s104, Duncan Churchill, Laura Waters, Nadia Ahmed, Brian Angus, Marta Boffito, Mark Bower, David Dunn, Simon Edwards, Carol Emerson, Sarah Fidler, Martin Fisher, Rob Horne, Saye Khoo, Clifford Leen, Nicola Mackie, Neal Marshall, Fernando Monteiro, Mark Nelson, Chloe Orkin, Adrian Palfreeman, Sarah Pett, Andrew Phillips, Frank Post, Anton Pozniak, Iain Reeves, Caroline Sabin, Roy Trevelion, John Walsh, Ed Wilkins, Ian Williams and Alan Winston

    Version of Record online : 29 AUG 2016, DOI: 10.1111/hiv.12426